Literature DB >> 11849561

Abnormal ubiquitination of axons in normally myelinated white matter in multiple sclerosis brain.

M T Giordana1, P Richiardi, E Trevisan, A Boghi, L Palmucci.   

Abstract

The hallmark of the lesions in multiple sclerosis (MS) is inflammatory demyelination with sparing of axons. Recent neuropathological and neuroradiological investigations show that structural changes of the axons occur, both in plaques and in the normal appearing white matter. A better understanding of the axonal damage in MS is important, since this may be responsible for permanent disability. We have investigated the immunoreactivity for ubiquitin, a sensitive method to detect axonal dystrophy and accumulation of abnormal proteins in pathological conditions of the nervous system, in the brains of six cases of MS (age range 39-66 years). Tissue blocks were fixed in formalin and embedded in paraffin. A panel of antibodies was used: anti-ubiquitin, anti-neurofilament (SMI-31 + SMI-32), anti-amyloid precursor protein and anti-PGP9.5. We focused our attention on chronic plaques, recognized by the absence of Luxol Fast Blue B-positive inclusions in macrophages. SMI-31 + SMI-32 showed the presence of a variable amount of axons within the plaques; the axonal network within the plaques was looser than outside. No ubiquitin reactivity was present in chronic plaques. In the normally myelinated white matter surrounding the plaques, a dense granular ubiquitin immunoreactivity was found both near and far from the plaque edge. No similar staining was found in control brains. Ubiquitination is the first step of a non-lysosomal degradation pathway of proteins. The present findings suggest a derangement of this proteolytic pathway in the axons outside the plaques, possibly as a consequence of chronic absence of myelin in the axonal segment inside the plaque. The spectrum of axonal changes in MS appears to be wider than expected and involves the apparently normal white matter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849561     DOI: 10.1046/j.1365-2990.2002.00372.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Determination of multiple sclerosis plaque size with diffusion-tensor MR Imaging: comparison study with healthy volunteers.

Authors:  Susan M Kealey; Youngjoo Kim; Wythe L Whiting; David J Madden; James M Provenzale
Journal:  Radiology       Date:  2005-08       Impact factor: 11.105

2.  Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2011-02-09       Impact factor: 5.372

3.  Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis.

Authors:  Arnaud Nicot; Michael Kurnellas; Stella Elkabes
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

4.  Reduced proteasomal activity contributes to the accumulation of carbonylated proteins in chronic experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2010-11-19       Impact factor: 5.372

5.  Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.

Authors:  Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

6.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

7.  Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Authors:  Kicheol Kim; Anne-Katrin Pröbstel; Ryan Baumann; Julia Dyckow; James Landefeld; Elva Kogl; Lohith Madireddy; Rita Loudermilk; Erica L Eggers; Sneha Singh; Stacy J Caillier; Stephen L Hauser; Bruce A C Cree; Lucas Schirmer; Michael R Wilson; Sergio E Baranzini
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

8.  Trophic factors are essential for the survival of grafted oligodendrocyte progenitors and for neuroprotection after perinatal excitotoxicity.

Authors:  Megumi Hirose-Ikeda; Brian Chu; Paul Zhao; Omar Akil; Elida Escalante; Laurent Vergnes; Carlos Cepeda; Araceli Espinosa-Jeffrey
Journal:  Neural Regen Res       Date:  2020-03       Impact factor: 5.135

Review 9.  Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases.

Authors:  Dhananjay Yadav; Ji Yeon Lee; Nidhi Puranik; Pallavi S Chauhan; Vishal Chavda; Jun-O Jin; Peter C W Lee
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.